Latest Breaking News On - Medication management solutions - Page 7 : comparemela.com

BD Announces Second Fiscal Quarter Results; Reaffirms Fiscal 2021 Guidance

BD Announces Second Fiscal Quarter Results; Reaffirms Fiscal 2021 Guidance - Second fiscal quarter revenues of $4.9 billion grew 15.4% on a reported basis. On a currency-neutral basis, revenues increased 12.2%. - BD s COVID-19 testing sales were $480 million, including BD Veritor™ Plus System revenues of $290 million. - BD s core growth led by strong growth in Medication Delivery Solutions (up 10.4%), Pharmaceutical Systems (up 15.4%), and Biosciences (up 16.3%) on a reported basis. - Second fiscal quarter GAAP diluted earnings per share (EPS) increased 77.4% year-over-year to $0.94. - Adjusted EPS increased 25.1% year-over-year to $3.19. - BD is reaffirming its fiscal 2021 revenue growth and adjusted EPS guidance. News provided by Share this article

BD Announces FDA 510(k) Submission for BD Alaris™ System

BD Announces FDA 510(k) Submission for BD Alaris™ System

BD Acquires GSL Solutions, Inc., Broadening Medication Management Offerings for Retail, Outpatient Pharmacy Settings

Share this article FRANKLIN LAKES, N.J., March 4, 2021 /PRNewswire/  BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired GSL Solutions, Inc. ( GSL ), a privately-held company that develops smart medication devices for the storage and tracking of controlled substances and patient specific medications that improve the security, efficiency and compliance of medication storage, as well as analytic capabilities to further improve inventory management, including of controlled substances, regulatory compliance and patient safety.  This acquisition expands BD s advanced medication management capabilities to further meet the needs of retail pharmacies, including those in outpatient settings.

Becton Dickinson & Co. (BDX) Q1 2021 Earnings Call Transcript

Operator Hello, and welcome to BD s First Fiscal Quarter 2021 Earnings Call. [Operator Instructions] It will be available for replay through February 11th 2021, on the Investors page of the bd.com website or by phone at 855-859-2056 for domestic calls and area code 404-537-3406 for international calls, using confirmation number 699-3448. [Operator Instructions] Beginning today s call is Ms. Kristen Stewart, Senior Vice President of Strategy and Investor Relations. Ms. Stewart, you may begin. Kristen Stewart Senior Vice President of Strategy and Investor Relations Thanks, Stephanie, and welcome to BD s review of our first fiscal quarter results. Joining me today, we have Tom Polen, Chief Executive Officer and President; Chris Reidy, Executive Vice President, Chief Financial Officer and Chief Administrative Officer. During the Q&A portion of the call, we will have our three segment presidents joining us as well, Alberto Mas, President of the Medical segment; Dave Hickey, Presid